Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.53 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.53 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 3/20 | 0.46 |
| ▸ | PPARG | P37231 | 2/20 | 0.44 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15547360 | 1.00 | FFAR1 (0.53) | FFAR1FFAR4GPR84MEN1CYP3A4 | |
| SCHEMBL28585490 | 1.00 | FFAR1 (0.53) | FFAR1FFAR4GPR84MEN1CYP3A4 | |
| SCHEMBL6015976 | 1.00 | FFAR1 (0.53) | FFAR1FFAR4GPR84MEN1CYP3A4 | |
| SCHEMBL31197028 | 0.98 | FFAR1 (0.51) | FFAR1FFAR4GPR84MEN1CYP3A4 | |
| SCHEMBL21552054 | 0.92 | FFAR1 (0.45) | FFAR1FFAR4GPR84MEN1CYP3A4 | |
| SCHEMBL21552055 | 0.92 | FFAR1 (0.45) | FFAR1FFAR4GPR84MEN1CYP3A4 | |
| SCHEMBL10081525 | 0.90 | FFAR1 (0.62) | FFAR1FFAR4GPR84MEN1CYP3A4 | |
| SCHEMBL2826342 | 0.90 | FFAR1 (0.62) | FFAR1FFAR4GPR84MEN1CYP3A4 | |
| SCHEMBL3185051 | 0.90 | FFAR1 (0.62) | FFAR1FFAR4GPR84MEN1CYP3A4 | |
| SCHEMBL17744144 | 0.90 | FFAR1 (0.62) | FFAR1FFAR4GPR84MEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8471007-B2 | Method for producing 1,3,5-triazine carbamates and ureas | BASF SE (DE) | 2013-06-25 | — | — | US | claimed |
| EP-0553663-B1 | Process for the preparation of thixotropic varnish binders based on alkyd resins | BAYER AG (DE) | 1995-05-03 | — | — | EP | claimed |
| EP-0553663-A1 | Process for the preparation of thixotropic varnish binders based on alkyd resins | BAYER AG (DE) | 1993-08-04 | — | — | EP | claimed |
| EP-3420053-A1 | ALKYLENE OXIDE- AND HYDROCARBYL-SUBSTITUTED POLYCARBOXYLIC ACID OF QUATERNIZED NITROGEN COMPOUNDS AS FRICTION-REDUCING ADDITIVE FOR FUELS | BASF SE (DE) | 2019-01-02 | — | — | EP | disclosed |
| WO-2017144376-A1 | ALKYLENE OXIDE- AND HYDROCARBYL-SUBSTITUTED POLYCARBOXYLIC ACID OF QUATERNIZED NITROGEN COMPOUNDS AS FRICTION-REDUCING ADDITIVE FOR FUELS | BASF SE (DE) | 2017-08-31 | — | — | WO | disclosed |
| WO-2017144378-A1 | HYDROPHOBIC POLYCARBOXYLIC ACIDS AS FRICTION-REDUCING ADDITIVE FOR FUELS | BASF SE (DE) | 2017-08-31 | — | — | WO | disclosed |
| WO-2017125358-A1 | METHOD FOR THE HOMOGENEOUSLY CATALYZED PRODUCTION OF MONO-N-SUBSTITUTED PIPERAZINES | BASF SE (DE) | 2017-07-27 | — | — | WO | disclosed |
| US-20150272891-A1 | DOSAGE FORMS COMPRISING APIXABAN AND MATRIX FORMER | RATIOPHARM GMBH (DE) | 2015-10-01 | — | — | US | disclosed |
| EP-2854759-A1 | DOSAGE FORMS COMPRISING APIXABAN AND MATRIX FORMER | ratiopharm GmbH (DE) | 2015-04-08 | — | — | EP | disclosed |
| WO-2014023549-A1 | METHOD FOR PRODUCING AMINES BY HOMOGENEOUSLY-CATALYZED ALCOHOL AMINATION IN THE PRESENCE OF A COMPLEX CATALYST, WHICH CONTAINS IRIDIUM AND AN AMINO ACID | BASF SE (DE) | 2014-02-13 | — | — | WO | disclosed |
| US-20140046054-A1 | PROCESS FOR PREPARING AMINES BY HOMOGENEOUSLY CATALYZED ALCOHOL AMINATION IN THE PRESENCE OF A COMPLEX CATALYST COMPRISING IRIDIUM AND AN AMINO ACID | BASF SE (DE) | 2014-02-13 | — | — | US | disclosed |
| US-20010025020-A1 | Compression process for multiphase tablets | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN(HENKEL KGAA) (DE) | 2001-09-27 | — | — | US | disclosed |
| WO-2001044436-A1 | METHOD FOR COMPACTING MULTI-PHASE DETERGENT AND CLEANSING-AGENT SHAPED BODIES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-06-21 | — | — | WO | disclosed |
| WO-2001042416-A1 | PRESSING METHOD FOR MULTI-PHASE MOULDED BODIES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-06-14 | — | — | WO | disclosed |
| WO-2001027234-A1 | CLEANING AGENT COMPONENTS WITH DUAL-CONTROLLED FRAGRANCE RELEASE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-04-19 | — | — | WO | disclosed |
| WO-2001019948-A1 | CLEAR RINSING AGENT | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-03-22 | — | — | WO | disclosed |
| WO-2001016283-A1 | DETERGENT CONSTITUENT | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-03-08 | — | — | WO | disclosed |
| US-5776934-A | Use of 1,3,5-triazine-2,4,6-tris-alkylaminocarboxylic acid derivatives as biocidal agents in aqueous systems and cooling lubricants comprising these | CG-CHEMIE GMBH (DE) | 1998-07-07 | — | — | US | disclosed |
| EP-0553663-B1 | Process for the preparation of thixotropic varnish binders based on alkyd resins | BAYER AG (DE) | 1995-05-03 | — | — | EP | disclosed |
| EP-0553663-A1 | Process for the preparation of thixotropic varnish binders based on alkyd resins | BAYER AG (DE) | 1993-08-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150272891-A1 | DOSAGE FORMS COMPRISING APIXABAN AND MATRIX FORMER | VKORC1, VKORC1L1, PROC | FFAR1 3394/4885FFAR4 2662/4885GPR84 3799/4885 |
| US-20140046054-A1 | PROCESS FOR PREPARING AMINES BY HOMOGENEOUSLY CATALYZED ALCOHOL AMINATION IN THE PRESENCE OF A COMPLEX CATALYST COMPRISING IRIDIUM AND AN AMINO ACID | ADH1A, ADH5, ADH1C | FFAR1 3610/4885FFAR4 3772/4885GPR84 1592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.